MENU

SGEN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Seagen (SGEN) Ownership - Who owns Seagen?

Seagen (formerly known as Seattle Genetics) is a biotech firm that develops and commercializes therapies to treat cancers... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

21823 - 30th Drive South East

Phone

+1 425 527-4000

Employees

3256

Web

https://www.seagen.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

40.45B

P/E Ratio

52.91

Total Cash

1.24B

Projected Growth

41.72

Total Debt

113.49M

Revenue

2.3B

Risk (Beta)

0.01

Dividend Yield

N/A

Total Cash/Share

6.56

Total Debt/Equity

N/A

Revenue/Share

12.29 USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for SGEN

A.I. Advisor

published General Information

General Information

a developer of monoclonal antibody-based therapeutic products for the treatment of cancer and immunologic diseases

Industry Biotechnology

Profile

Details

Industry

Biotechnology

Address

21823 - 30th Drive South East

Phone

+1 425 527-4000

Employees

3256

Web

https://www.seagen.com